🇺🇸 FDA
Patent

US 10449231

Compositions and methods for dengue virus chimeric constructs in vaccines

granted A61KA61K2039/5254A61K2039/70

Quick answer

US patent 10449231 (Compositions and methods for dengue virus chimeric constructs in vaccines) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/5254, A61K2039/70, A61K31/7048, A61K31/713